Morgan Stanley (AMN) discloses 2.08M-share beneficial stake in AMN Healthcare

Rhea-AI Filing Summary

Morgan Stanley, through certain reporting units, reports a passive ownership stake in AMN Healthcare Services, Inc. common stock. As of June 30, 2026, the filing shows 2,076,006 shares beneficially owned, representing 5.4% of AMN’s common stock. Morgan Stanley reports no sole voting or dispositive power, with shared voting power over 2,075,030 shares and shared dispositive power over 2,076,006 shares. The disclosure applies only to certain Morgan Stanley operating units, with other units, if any, disaggregated under applicable SEC guidance.

Key Figures

Shares beneficially owned: 2,076,006 shares Percent of class: 5.4% Shared voting power: 2,075,030 shares +3 more

6 metrics

Shares beneficially owned 2,076,006 shares AMN Healthcare common stock beneficially owned as of June 30, 2026

Percent of class 5.4% Portion of AMN Healthcare common stock reported as beneficially owned

Shared voting power 2,075,030 shares AMN Healthcare shares over which Morgan Stanley has shared voting power

Shared dispositive power 2,076,006 shares AMN Healthcare shares over which Morgan Stanley has shared dispositive power

Sole voting power 0 shares AMN Healthcare shares over which Morgan Stanley has sole voting power

Sole dispositive power 0 shares AMN Healthcare shares over which Morgan Stanley has sole dispositive power

Key Terms

beneficially owned, shared voting power, shared dispositive power, Schedule 13G, +1 more

5 terms

beneficially owned regulatory

"this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"Shared Voting Power 2,075,030.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 2,076,006.00"

Schedule 13G regulatory

"In Accordance with the Release No. 34-39538 ... this filing reflects the securities"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

MS Reporting Units regulatory

"beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley"

FAQ

What ownership stake does Morgan Stanley report in AMN (AMN)?

Morgan Stanley reports beneficial ownership of 2,076,006 AMN Healthcare common shares, representing 5.4% of the company’s common stock as of June 30, 2026, according to its Schedule 13G filing.

Does Morgan Stanley have voting control over AMN (AMN) shares?

Morgan Stanley reports no sole voting power over AMN shares, but discloses shared voting power over 2,075,030 shares through certain reporting units identified in the Schedule 13G.

How many AMN (AMN) shares can Morgan Stanley dispose of?

Morgan Stanley reports no sole dispositive power but has shared dispositive power over 2,076,006 AMN common shares, meaning those shares can be disposed of jointly by the relevant Morgan Stanley reporting units.

Is Morgan Stanley’s AMN (AMN) position reported as beneficial ownership?

Yes. Morgan Stanley reports beneficial ownership of AMN shares on a Schedule 13G, reflecting securities beneficially owned, or deemed beneficially owned, by certain Morgan Stanley operating units under SEC Release No. 34-39538.

Are all Morgan Stanley units included in this AMN (AMN) ownership report?

No. The filing states it covers only certain Morgan Stanley reporting units. Any units whose ownership is disaggregated under SEC Release No. 34-39538 are not included in the reported AMN holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 04:36 PM Accepted by SEC EDGAR 08/13/2026 - 04:35 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

AMN HEALTHCARE SERVICES, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

001744101

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 001744101

1

Names of Reporting Persons

Morgan Stanley

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,075,030.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,076,006.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,076,006.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

HC, CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: AMN HEALTHCARE SERVICES, INC.
(b)	Address of issuer's principal executive offices: 2999 OLYMPUS BOULEVARD, SUITE 500, DALLAS, TX, 75019
Item 2.
(a)	Name of person filing: Morgan Stanley
(b)	Address or principal business office or, if none, residence: 1585 Broadway, New York, NY 10036
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 001744101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: 5.4 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Morgan Stanley

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley
Date:	08/13/2026